Navigation Links
Assay Designs(TM), Inc. Announces Agreement with Abnova Corp. of Taiwan
Date:11/5/2008

ANN ARBOR, Mich., Nov. 5 /PRNewswire/ -- Assay Designs, Inc., a leading provider of immunoassay kits, antibodies, and reagents to the life science and translational research markets, has announced a strategic agreement with Abnova Corporation of Taiwan. The agreement enables Assay Designs to distribute approximately 3,200 of Abnova's highly characterized monoclonal antibodies to their U.S. and Canadian customers. This major product addition expands Assay Designs' current product portfolio to include over 5,300 reagents for important research areas such as cell signaling, cellular stress, neuroscience, and inflammation.

"This new partnership with Abnova expands our current product portfolio tremendously with high quality monoclonals for a broad range of applications and research areas," stated Dan Calvo, CEO of Assay Designs. "Abnova's capacity to develop and produce antibodies is very complementary to our current antibody and immunoassay businesses, and affords our customer base easy access to their most highly characterized monoclonals for applications such as ELISA, immunohistochemistry, and immunofluorescence as well as western blotting."

Abnova's mission is to be the world's largest antibody distributor. They have the capacity of generating 500 mouse monoclonal antibodies and 500 rabbit polyclonal antibodies per month. "We are very pleased to be collaborating with Assay Designs on broadening the exposure and accessibility of Abnova antibody and proteins products in the research market," states Wilbur Huang, CEO of Abnova. "Moreover, Assay Designs' expertise in immunoassay and system development highly complements Abnova's capability in industrial-scale antibody manufacturing based on 'one gene one antibody' translation of the human genome. Assay Designs and Abnova will work closely together to realize next generation of analytical products which will accelerate the translational research in the proteomics era."

About Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets these products under the Assay Designs and Stressgen(R) brand names. Researchers use the company's products to detect and quantify molecules that are important in inflammation, cell signaling, and cellular stress. New assay platforms include MultiBead(TM) bead-based multiplex immunoassay kits and ImmunoSet(TM) ELISA development reagents.

About Anbova Corporation

Abnova is a bio-tool proteomic company specializing in automated, high throughput protein expression and antibody production. The system Abnova has developed is a unique combination of world-class technologies and management experience of the IT industry in Taiwan. The company's goal is to vastly expand the scope and availability of bio-tool reagents. As such, it is a taking a genome-wide approach to the production of human recombinant protein and antibody, and is developing a portfolio of integrated and systemized applications including immuno- and multiplex-assays covering protein families that are essential to the drug discovery and diagnostic industries.


'/>"/>
SOURCE Assay Designs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Exiqon Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer
2. The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
3. Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure
4. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
5. CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit
6. MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting
7. Monogram and Dana-Farber Cancer Institute Initiate Evaluation of HERmark(TM) Breast Cancer Assay in Metastatic Breast Cancer
8. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
9. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
10. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
11. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is ... projects are designed, built and brought to market. , The Design Lab is ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):